Effectiveness of Psychotropic Medications in Children with Prenatal Alcohol and Drug Exposures: A Case Series and Model of Care

May PA, Chambers CD, Kalberg WO, Zellner J, Feldman H, Buckley D et al (2018) Prevalence of Fetal Alcohol Spectrum Disorders in 4 US Communities. JAMA 319:474–482

Article  PubMed  PubMed Central  Google Scholar 

Makadia LD, Roper PJ, Andrews JO, Tingen MS (2017) Tobacco use and smoke exposure in children: new trends, harm, and strategies to improve health outcomes. Curr Allergy Asthma Rep 17:55

Article  PubMed  Google Scholar 

Buckingham-Howes S, Berger SS, Scaletti LA, Black MM (2013) Systematic review of prenatal cocaine exposure and adolescent development. Pediatrics 131:e1917-1936

Article  PubMed  PubMed Central  Google Scholar 

O’Connor MJ, Paley B (2009) Psychiatric conditions associated with prenatal alcohol exposure. Dev Disabil Res Rev 15:225–234

Article  PubMed  Google Scholar 

Mattson SN, Bernes GA, Doyle LR (2019) Fetal Alcohol Spectrum Disorders: a review of the neurobehavioral deficits associated with prenatal alcohol exposure. Alcohol Clin Exp Res 43:1046–1062

Article  PubMed  PubMed Central  Google Scholar 

Jones KL (2011) The effects of alcohol on fetal development. Birth Defects Res C Embryo Today 93:3–11

Article  PubMed  Google Scholar 

Mukherjee RAS, Cook PA, Norgate SH, Price AD (2019) Neurodevelopmental outcomes in individuals with Fetal Alcohol Spectrum Disorder (FASD) with and without exposure to neglect: clinical cohort data from a national FASD diagnostic clinic. Alcohol 76:23–28

Article  PubMed  Google Scholar 

Chambers CD, Coles C, Kable J, Akshoomoff N, Xu R, Zellner JA et al (2019) Fetal Alcohol Spectrum Disorders in a Pacific Southwest City: maternal and child characteristics. Alcohol Clin Exp Res 43:2578–2590

Article  PubMed  PubMed Central  Google Scholar 

Fryer SL, McGee CL, Matt GE, Riley EP, Mattson SN (2007) Evaluation of psychopathological conditions in children with heavy prenatal alcohol exposure. Pediatrics 119:e733-741

Article  PubMed  Google Scholar 

Frankel F, Paley B, Marquardt R, O’Connor M (2006) Stimulants, neuroleptics, and children’s friendship training for children with Fetal Alcohol Spectrum Disorders. J Child Adolesc Psychopharmacol 16:777–789

Article  PubMed  Google Scholar 

Ritfeld GJ, Kable JA, Holton JE, Coles CD (2022) Psychopharmacological treatments in children with Fetal Alcohol Spectrum Disorders: a review. Child Psychiatry Hum Dev 53:268–277

Article  PubMed  Google Scholar 

Oesterheld JR, Kofoed L, Tervo R, Fogas B, Wilson A, Fiechtner H (1998) Effectiveness of methylphenidate in Native American children with fetal alcohol syndrome and attention deficit/hyperactivity disorder: a controlled pilot study. J Child Adolesc Psychopharmacol 8:39–48

Article  PubMed  Google Scholar 

O’Malley KD, Koplin B, Dohner VA (2000) Psychostimulant clinical response in fetal alcohol syndrome. Can J Psychiatry 45:90–91

PubMed  Google Scholar 

Doig J, McLennan JD, Gibbard WB (2008) Medication effects on symptoms of attention-deficit/hyperactivity disorder in children with Fetal Alcohol Spectrum Disorder. J Child Adolesc Psychopharmacol 18:365–371

Article  PubMed  Google Scholar 

Snyder JNJ, Snyder R, Block G (1997) A study of stimulant medication in children with FAS. In: Streissguth AKJ (ed) Overcoming and preventing secondary disabilities in fetal alcohol syndrome and fetal alcohol effects. University of Washington Press, Seattle, pp 64–77

Google Scholar 

Coe JSJ, Riley K, Waltermire J, Hagerman R (2001) A survey of medication responses in children and adolescents with fetal alcohol syndrome. Mental Health Aspects Dev Disabil 4:148–155

Google Scholar 

Pliszka S (2007) Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 46:894–921

Article  PubMed  Google Scholar 

Coles CD, Platzman KA, Raskind-Hood CL, Brown RT, Falek A, Smith IE (1997) A comparison of children affected by prenatal alcohol exposure and attention deficit, hyperactivity disorder. Alcohol Clin Exp Res 21:150–161

Article  PubMed  Google Scholar 

Wozniak JR, Fuglestad AJ, Eckerle JK, Fink BA, Hoecker HL, Boys CJ et al (2015) Choline supplementation in children with Fetal Alcohol Spectrum Disorders: a randomized, double-blind, placebo-controlled trial. Am J Clin Nutr 102:1113–1125

Article  PubMed  PubMed Central  Google Scholar 

Nguyen TT, Risbud RD, Mattson SN, Chambers CD, Thomas JD (2016) Randomized, double-blind, placebo-controlled clinical trial of choline supplementation in school-aged children with Fetal Alcohol Spectrum Disorders. Am J Clin Nutr 104:1683–1692

Article  PubMed  PubMed Central  Google Scholar 

Wozniak JR, Fink BA, Fuglestad AJ, Eckerle JK, Boys CJ, Sandness KE et al (2020) Four-year follow-up of a randomized controlled trial of choline for neurodevelopment in Fetal Alcohol Spectrum Disorder. J Neurodev Disord 12:9

Article  PubMed  PubMed Central  Google Scholar 

Mela M, Okpalauwaekwe U, Anderson T, Eng J, Nomani S, Ahmed A et al (2018) The utility of psychotropic drugs on patients with Fetal Alcohol Spectrum Disorder (FASD): a systematic review. Psychiatry Clin Psychopharmacol 28:436–445

Article  Google Scholar 

Elliott CD (2007) Differential ability scales (2nd ed). Can J School Psychol 22:128–132.

Sparrow S, Balla D, Cichetti, D (1984) The vineland adaptive behavior scales: american guidance service. Circle Pines

Fernhoff PM, Smith IE, Falek A (1980) Dysmorphia checklist. Document available through the maternal substance abuse and child development project. Division of Psychiatry, Emory University, Atlanta

Google Scholar 

Coles CD, Gailey AR, Mulle JG, Kable JA, Lynch ME, Jones KL (2016) A comparison among 5 methods for the clinical diagnosis of Fetal Alcohol Spectrum Disorders. Alcohol Clin Exp Res 40:1000–1009

Article  PubMed  PubMed Central  Google Scholar 

Swanson JM, Kraemer HC, Hinshaw SP, Arnold LE, Conners CK, Abikoff HB et al (2001) Clinical relevance of the primary findings of the MTA: success rates based on severity of ADHD and ODD symptoms at the end of treatment. J Am Acad Child Adolesc Psychiatry 40:168–179

Article  PubMed  Google Scholar 

Coles CD, Kable JA, Taddeo E, Strickland DC (2015) A metacognitive strategy for reducing disruptive behavior in children with Fetal Alcohol Spectrum Disorders: GoFAR pilot. Alcohol Clin Exp Res 39:2224–2233

Article  PubMed  Google Scholar 

Achenbach TM (2017) Achenbach system of empirically based assessment (ASEBA). In: Kreutzer J, DeLuca J, Caplan B (eds) Encyclopedia of clinical neuropsychology. Springer, Cham, pp 1–7

Google Scholar 

Greenberg LM (2011) The test of variables of attention (version 8.0) [computer software]. The TOVA Company, Los Alamitos

Google Scholar 

Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B (Methodol) 57:289–300

Article  Google Scholar 

Randall S, Hannigan JH (1999) In utero alcohol and postnatal methylphenidate: locomotion and dopamine receptors. Neurotoxicol Teratol 21:587–593

Article  PubMed  Google Scholar 

Hannigan JH, Pilati ML (1991) The effects of chronic postweaning amphetamine on rats exposed to alcohol in utero: weight gain and behavior. Neurotoxicol Teratol 13:649–656

Article  PubMed  Google Scholar 

Ulug S, Riley EP (1983) The effect of methylphenidate on overactivity in rats prenatally exposed to alcohol. Neurobehav Toxicol Teratol 5:35–39

PubMed  Google Scholar 

Means LCM, Hughes V, Grey K (1984) Rats exposed in utero to ethanol are hyperresponsive to methylphenidate when tested as neonates or adults. Neurobehav Toxicol Teratol 6:187–192

PubMed  Google Scholar 

Juarez J, Guerrero-Alvarez A (2015) Effects of methylphenidate and atomoxetine on impulsivity and motor activity in preadolescent rats prenatally-treated with alcohol. Behav Neurosci 129:756–764

Article  PubMed  Google Scholar 

Glass L, Graham DM, Deweese BN, Jones KL, Riley EP, Mattson SN (2014) Correspondence of parent report and laboratory measures of inattention and hyperactivity in children with heavy prenatal alcohol exposure. Neurotoxicol Teratol 42:43–50

Article  PubMed  PubMed Central  Google Scholar 

Hanlon-Dearman A, Chen ML, Olson HC (2018) Understanding and managing sleep disruption in children with Fetal Alcohol Spectrum Disorder. Biochem Cell Biol 96:267–274

Article  PubMed  Google Scholar 

Durr MR, Petryk S, Mela M, Des Roches A, Wekerle M, Newaz S (2021) Utilization of psychotropic medications in children with FASD: a retrospective review. BMC Pediatr 21:512

留言 (0)

沒有登入
gif